PG
WST icon

PEAK6 Group’s West Pharmaceutical WST Stock Holding History

PEAK6 Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,900
Closed -$568K – 4873
2017
Q3 		$568K Buy
+5,900
New +$534K ﹤0.01% 2449
2017
Q1 		– Sell
-100
Closed -$8K – 5085
2016
Q4 		$8K Buy
+100
New +$7.86K ﹤0.01% 4546
2016
Q3 		– Sell
-11,000
Closed -$835K – 4756
2016
Q2 		$835K Sell
11,000
-4,100
-27% -$298K 0.01% 1944
2016
Q1 		$1.05M Sell
15,100
-24,900
-62% -$1.5M 0.01% 1627
2015
Q4 		$2.41M Sell
40,000
-1,000
-2% -$60.2K 0.02% 1204
2015
Q3 		$2.22M Buy
+41,000
New +$2.39M 0.01% 1497
2014
Q1 		– Sell
-2,200
Closed -$108K – 5457
2013
Q4 		$108K Buy
+2,200
New +$103K ﹤0.01% 3967

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

PEAK6 Group's WST Position: Q1 2017 in Review

PEAK6 Group sold out of West Pharmaceutical (WST) in Q1 2017, closing a stake of 343 shares — an estimated $29K sold.

PEAK6 Group first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $29K in Q4 2016. 295 funds tracked by Wall St. Rank hold WST as of Q1 2017.

  • PEAK6 Group reported no remaining West Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 343 West Pharmaceutical shares in Q1 2017, an estimated $29K.
  • PEAK6 Group first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
  • PEAK6 Group's West Pharmaceutical position peaked at $29K in Q4 2016.
  • 295 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.